Gamble Jones Investment Counsel Alaunos Therapeutics, Inc. Transaction History
Gamble Jones Investment Counsel
- $1.33 Billion
- Q4 2022
A detailed history of Gamble Jones Investment Counsel transactions in Alaunos Therapeutics, Inc. stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 61,000 shares of TCRT stock, worth $125,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,000
Previous 61,000
-0.0%
Holding current value
$125,049
Previous $105,000
62.86%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TCRT
# of Institutions
5Shares Held
92.6KCall Options Held
0Put Options Held
0About Alaunos Therapeutics, Inc.
- Ticker TCRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,182,000
- Market Cap $443M
- Description
- Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...